Glenmark Pharmaceuticals Limited (NSE:GLENMARK)
India · Delayed Price · Currency is INR 1,978.00
+43.20 (2.23%)
Feb 9, 2026, 3:29 PM IST
Glenmark Pharmaceuticals Market Cap
Glenmark Pharmaceuticals has a market cap or net worth of 546 billion as of February 9, 2026. Its market cap has increased by 28.68% in one year.
Market Cap
546.00B
Enterprise Value
531.34B
Revenue
165.10B
Ranking
n/a
PE Ratio
51.26
Stock Price
1,978.00
Market Cap Chart
Since June 7, 2001, Glenmark Pharmaceuticals's market cap has increased from 1.15B to 546.00B, an increase of 47,407.23%. That is a compound annual growth rate of 28.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 546.00B | -4.93% |
| Dec 31, 2025 | 574.34B | 26.49% |
| Dec 31, 2024 | 454.07B | 88.44% |
| Dec 29, 2023 | 240.96B | 101.33% |
| Dec 30, 2022 | 119.68B | -19.75% |
| Dec 31, 2021 | 149.14B | 7.10% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cipla | 1.07T |
| Zydus Lifesciences | 893.69B |
| Mankind Pharma | 850.46B |
| Aurobindo Pharma | 691.73B |
| Alkem Laboratories | 679.61B |
| Laurus Labs | 513.16B |
| Ipca Laboratories | 359.42B |
| Ajanta Pharma | 356.27B |